Skip to Content

VIA Pharmaceuticals Inc VIAP

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VIAP is trading at a 667% premium.
Price
$0.00
Fair Value
$8.25
Uncertainty
Extreme
1-Star Price
$9.38
5-Star Price
$9.38
Economic Moat
Ndkxc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VIAP is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.02
Market Cap
$20.56
Volume/Avg
700 / 1,263

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

VIA Pharmaceuticals Inc is a development stage biotechnology company focuses on the development of small-molecule drugs to treat cardiovascular and metabolic diseases.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
6
Website

Valuation

Metric
VIAP
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
VIAP
Quick Ratio
0.00
Current Ratio
0.02
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
VIAP
Return on Assets (Normalized)
−973.85%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRHkysxjrfzBphhl$586.1 Bil
VRTX
Vertex Pharmaceuticals IncCzscgkmdZhsmqv$113.7 Bil
REGN
Regeneron Pharmaceuticals IncDcyzbtkrJpsdvg$108.2 Bil
MRNA
Moderna IncBfnrmcdZgtk$50.9 Bil
ARGX
argenx SE ADRDtmxxjvjYmtd$22.0 Bil
BNTX
BioNTech SE ADRVngmqgwNyzd$21.8 Bil
ALNY
Alnylam Pharmaceuticals IncJpqfddmDswfkv$18.9 Bil
BMRN
Biomarin Pharmaceutical IncWkktygxjGxkqgth$14.6 Bil
INCY
Incyte CorpXqsvwffdjRzkvrv$12.8 Bil
RPRX
Royalty Pharma PLC Class AKmtwcwdrnTzdztr$12.3 Bil

Sponsor Center